RARE is trading at $30.77, up 5.2% versus the comparison close of $29.25 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 RARE extends move to 5.2% up
Ultragenyx
Related News
RARE
🟢 Ultragenyx is trading 4.64% up today after FDA’s accelerated approval of GENGLYCOS
RARE
🔴 Ultragenyx is trading 4.23% down today amid broader biotech pullback
RARE
Ultragenyx Stock Falls, Awaiting FDA Decision on Rare Disease Gene Therapy
RARE
Ultragenyx Lands Its First Gene Therapy — But Can a Tiny Patient Pool Justify the Stock's Leap of Faith?
RARE